STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Biotechnology
trading-chart-2

Biotech and Tech Stocks Surge Amid Promising Developments

byLuca Blaumann
May 20, 2024
in Biotechnology, Electrical Equipment, Micro-Cap
Reading Time: 3 mins read
Share on TwitterShare on LinkedIn

GT Biopharma Shares Soar 148% Amid Positive Q1 Updates and Promising Pipeline Developments

GT Biopharma Inc. (GTBP) has experienced a significant surge in its share price, climbing 148% as the company builds momentum from its recent Q1 earnings report and strategic corporate updates. The biopharmaceutical company, known for its innovative cancer therapies, has outlined several key milestones for the upcoming quarters, boosting investor confidence and market enthusiasm.

Key Developments Driving Growth

A major highlight from GT Biopharma’s recent announcements is the expected Investigational New Drug (IND) clearance for GTB-3650. This second-generation nanobody TriKE® (Tri-specific Killer Engager) is designed for the treatment of CD33+ leukemia. The IND clearance is anticipated in Q2 2024, with a Phase 1 clinical trial set to begin in the second half of 2024. GTB-3650 represents a significant advancement in targeted cancer therapy, leveraging nanobody technology to enhance the efficacy and specificity of treatment.

Additionally, the company plans to submit an IND for GTB-5550 in Q4 2024. GTB-5550 is another promising TriKE® therapy, this time targeting B7H3 positive solid tumors. The initiation of a Phase 1 dose escalation basket trial for GTB-5550 is also on the horizon, aiming to evaluate its effectiveness across six different solid tumor cancers, including prostate, breast, head and neck, ovarian, lung, and gastrointestinal cancers. This broad-spectrum approach highlights GT Biopharma’s commitment to addressing a wide range of oncological challenges.

Faraday Future’s Market Momentum

Faraday Future Intelligent Electric (FFIE) has also experienced a remarkable 90% increase in its share price. This surge is largely attributed to strong interest from retail investors, who are optimistic about the company’s future prospects in the electric vehicle (EV) market. Faraday Future has been working diligently to enhance its product offerings and market presence, aiming to capture a significant share of the growing EV sector.

MultiMetaVerse Holdings’ Strategic Acquisition

In the entertainment and technology sector, MultiMetaVerse Holdings (MMV) announced a major strategic move by entering a non-binding term sheet for the acquisition of Bowong Technology (Shenzhen) Co., Ltd. and its subsidiaries, collectively known as Bowong AI. The acquisition will be executed through the issuance of MMV’s Class A ordinary shares to Bowong AI’s shareholders, with the exact number of shares to be determined following due diligence and negotiations.

This acquisition is expected to bolster MMV’s capabilities in animation and entertainment for young consumers in China, further solidifying its market position. The Consideration Shares issued in the transaction will be subject to a one-year lock-up period, and MMV has an exclusive 90-day negotiation period to finalize the agreement.

Conclusion

The substantial gains in shares of GT Biopharma, Faraday Future, and MultiMetaVerse Holdings reflect a broader trend of investor confidence in companies making significant strides in their respective fields. GT Biopharma’s innovative cancer therapies, Faraday Future’s advancements in the EV market, and MultiMetaVerse Holdings’ strategic acquisitions highlight the diverse opportunities driving market enthusiasm. Investors will be closely monitoring these companies as they progress through key milestones and continue to develop their groundbreaking technologies and business strategies.

You might like this article:Amgen’s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment

Tags: GrowthMoversNewsStock Market
Previous Post

Amgen’s Imdelltra Receives FDA Approval as Breakthrough Lung Cancer Treatment

Next Post

Wix Reports Stellar Q1 2024 Results, Anticipates Significant Revenue Growth in 2025

Related Posts

Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast

byLuca Blaumann
August 5, 2025
0

Telehealth company maintains 2025 outlook, expands beyond GLP-1 offerings amid regulatory and partnership setbacks Hims & Hers Health (HIMS) stock...

airplane

FAA Keeps Boeing 737 MAX Production Cap in Place Amid Ongoing Oversight

byLiliana Vida
July 24, 2025
0

Regulator says improvements are underway but more evidence needed before raising limits The Federal Aviation Administration (FAA) has not received...

investing

GoPro and Krispy Kreme Surge as Meme Stock Frenzy Reignites

byLuca Blaumann
July 23, 2025
0

Retail traders push small caps higher despite shaky fundamentals A fresh wave of meme stock mania swept through markets on...

Next Post
trading-chart

Wix Reports Stellar Q1 2024 Results, Anticipates Significant Revenue Growth in 2025

Latest News

Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast

Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

Tesla Board Approves $29 Billion Alternative Compensation Plan for Elon Musk

Blade Air Mobility Sells Rideshare Business to Joby Aviation for $125 Million

Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth

Based on Your Interest

Aerospace & Defense

Palo Alto Networks Eyes $20B Deal for CyberArk

July 29, 2025
trading-chart
Ecommerece

AMD and Amazon: Two Titans Poised for Explosive Growth

July 28, 2025
Entertainment

FCC Approves $8B Paramount-Skydance Merger Amid Political Controversy

July 25, 2025

Recommended

Aerospace & Defense

FAA Keeps Boeing 737 MAX Production Cap in Place Amid Ongoing Oversight

July 24, 2025
Large-Cap

Intel Beats on Revenue, Misses on Earnings; Cuts Workforce by 15%

July 24, 2025
Brokerages

Accelerant Soars in NYSE Debut, Valued at $6.4 Billion

July 24, 2025
Distributor

GoPro and Krispy Kreme Surge as Meme Stock Frenzy Reignites

July 23, 2025
Electrical Equipment

GE Vernova Soars to Record High on Raised Cash Flow Outlook

July 23, 2025
Stoxpo

Follow us on social media:

Highlights

  • Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast
  • Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom
  • Tesla Board Approves $29 Billion Alternative Compensation Plan for Elon Musk
  • Blade Air Mobility Sells Rideshare Business to Joby Aviation for $125 Million
  • Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast

August 5, 2025
trading-chart-2

Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

August 4, 2025
tesla

Tesla Board Approves $29 Billion Alternative Compensation Plan for Elon Musk

August 4, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?